1. Home
  2. PMAX vs CDT Comparison

PMAX vs CDT Comparison

Compare PMAX & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • CDT
  • Stock Information
  • Founded
  • PMAX 2019
  • CDT 2019
  • Country
  • PMAX Hong Kong
  • CDT United States
  • Employees
  • PMAX N/A
  • CDT N/A
  • Industry
  • PMAX
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMAX
  • CDT Health Care
  • Exchange
  • PMAX Nasdaq
  • CDT Nasdaq
  • Market Cap
  • PMAX 4.7M
  • CDT 5.3M
  • IPO Year
  • PMAX 2024
  • CDT N/A
  • Fundamental
  • Price
  • PMAX $0.34
  • CDT $0.39
  • Analyst Decision
  • PMAX
  • CDT
  • Analyst Count
  • PMAX 0
  • CDT 0
  • Target Price
  • PMAX N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • PMAX 1.6M
  • CDT 768.1K
  • Earning Date
  • PMAX 04-28-2025
  • CDT 05-15-2025
  • Dividend Yield
  • PMAX N/A
  • CDT N/A
  • EPS Growth
  • PMAX N/A
  • CDT N/A
  • EPS
  • PMAX N/A
  • CDT N/A
  • Revenue
  • PMAX $4,694,079.00
  • CDT N/A
  • Revenue This Year
  • PMAX N/A
  • CDT N/A
  • Revenue Next Year
  • PMAX N/A
  • CDT N/A
  • P/E Ratio
  • PMAX N/A
  • CDT N/A
  • Revenue Growth
  • PMAX N/A
  • CDT N/A
  • 52 Week Low
  • PMAX $0.28
  • CDT $0.51
  • 52 Week High
  • PMAX $4.70
  • CDT $350.00
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • CDT 31.63
  • Support Level
  • PMAX N/A
  • CDT $0.38
  • Resistance Level
  • PMAX N/A
  • CDT $0.41
  • Average True Range (ATR)
  • PMAX 0.00
  • CDT 0.04
  • MACD
  • PMAX 0.00
  • CDT 0.01
  • Stochastic Oscillator
  • PMAX 0.00
  • CDT 9.89

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: